|09-15-2017 08:28 AM CET - Health & Medicine||
Global Advanced Wound Care Market by Wound Type, End Users, Distribution Channel and Geography till 2024
Press release from: Data Bridge Market Research
The new market report “Global Advanced Wound Care Market” is expected to reach USD 22,088.6 million by 2024 from USD 11,683.5 million in 2016, at a CAGR of 8.4% in the forecast period 2017 to 2024.
Market Segmentation: Global Advanced Wound Care Market
By Type (Dressings, Biologics, Therapy Devices),Wound Type (Surgical Wounds, Diabetic Ulcers, Pressure Ulcers, Venous Ulcers, Burns, Other Traumatic Wounds), End Users (Hospitals, Wound Care Centers, Ambulatory Centers, Clinics, Community Healthcare, Home Healthcare),Distribution Channel (Direct Tenders Public, Retail Private),Geography (North America, Europe, Asia Pacific, South America, Middle East and Africa)
Market Drivers: Global Advanced Wound Care Market
Some of the major factors driving the growth of market for advanced wound care market, such as technological advancement, rising incidences of chronic wound, government support, rising geriatric population and increasing trend.
RISING GERIATRIC POPULATION
With our aging population, diseases that compromise skin integrity such as diabetes, skin breakdown with ulcer and chronic wound formation is a frequent consequence. Type of wounds includes pressure ulcers, surgical wounds, venous ulcers, traumatic wounds, arterial wounds, diabetic ulcers and chronic ulcers. There is a strong correlation between age and the incidence of diseases requiring wound products.
Ask For A Sample Of This Report: databridgemarketresearch.com/request-a-sample/?dbmr=globa...
Wounds are unique as far as no disease other than wounds would have existed from the beginning of mankind. Over the years, the management of wounds, especially that of chronic wounds, have enormous social and economic implications worldwide. The increasing prevalence of chronic wounds is the driving demand for products which better enhance quality of life and limit the risk of more serious health problems. As a result, treatment and management is moving from traditional wound care products to more advanced offerings which provide an optimal healing environment. These advanced technologies include foam, alginates, gelling fibrous dressings and anti-infective substances such as silver. Continuous advances made in the study of the wound, an ever-broadening understanding of the path physiology of wounds, and advanced technology in monitoring the response of healing has led to continuous developments in the treatment of different wounds
RISING INCIDENCES OF CHRONIC WOUND
Chronic wounds are rarely seen in individuals. In fact, chronic wound patients frequently suffer from “highly branded” diseases such as diabetes and obesity. Some of the most common types of wounds are infectious wounds, ischemic wounds, radiation poisoning wounds and surgical wounds. Ulcers is the most common type of chronic wounds, some of the most common types of ulcers are arterial ulcers, venous ulcers, diabetic ulcers and pressure ulcer. Tree of chronic wound is growing steadily; it increases incidence of chronic wound in individuals. People are suffering from different type of wounds and ulcers.
Wound healing is an inherent ability of an organism to protect itself against injuries. Government of every region support in the form of funding for advance wound care development, innovations and helps in increasing trend towards preventive healthcare. For instance, Willingsford Healthcare, a small British company is to receive government grant to develop its innovative wound treatment.
Some of the prominent players in the advanced wound care market are
• Smith and Nephew
• Acelity L.P. INC
• Molnlycke Healthcare AB
• Convatec Inc
• Ethicon. Inc
• Hollister Inc
• Integra Life Sciences Corporation
• Derma Sciences Inc
• Spiracur Inc
• Medline Industries
• Mimedx Group
• Organogenesis Inc
• Talley Group
• BSN Medical
• Devon Medical Products
• Human Biosciences Inc
• B. Braun Melsungen AG
• Cardinal Health
• Paul Hartmann Limited
• DeRoyal Industries Inc
• DermaRite Industries LLC
• MPM Medical Inc
• Kinetic Concepts
• Advancis Medical
• Many others.
Inquiry before Buying: databridgemarketresearch.com/inquire-before-buying/?dbmr=...
Acelity L.P. INC. is dominated the advanced wound care market in 2016 followed by Smith and Nephew, and Molnlycke Healthcare AB. Other players in this market include 3M, Medtronic, Convatec Inc, Baxter, Coloplast, Ethicon. Inc, Hollister Inc, Integra Life Sciences Corporation, Derma Sciences Inc, Spiracur Inc, Medline Industries, MiMedx Group, Organogenesis Inc, Talley Group Limited, BSN Medical, Devon Medical Products.com, Human Biosciences Inc, B.BraunMelsungen AG, Cardinal Health, Paul Hartmann Ltd, DeRoyal Industries Inc, DermaRite Industries LLC, MPM Medical Inc, KCL Licensing Inc., Advancis Medical among others holds 26.0% of the global advanced wound care market in 2016.
SMITH AND NEPHEW:
Smith and Nephew was founded in 1856, and headquartered in London, U.K. The Company supports healthcare professionals in more than 100 countries in their daily efforts to improve the lives of their patients by taking a pioneering approach to the design of our advanced medical products and services, by securing wider access to their diverse technologies for more customers globally, and by enabling better outcomes for patients and healthcare systems. The company’s operations span across North America, Europe, Middle East, Africa, Asia, and rest of the world. Smith and Nephew operate through four business segments: orthopedics reconstruction, advanced wound management, sports medicine, and trauma & extremities.
In December 2016, Smith and Nephew was awarded the 2016 French Galien Award for PICO; the novel single-use negative pressure wound therapy (NPWT) system.
Browse Full Report Visit @ databridgemarketresearch.com/reports/global-advanced-woun...
Global Active Wound Care Market – Industry Trends and Forecast to 2024
Global Active Wound Care Market By Product Type (Allograft, Synthetic Skin Grafts, Xenografts, Collagen Dressings, Amniotic Tissue Grafts, Growth Factors (Platelet Derived Growth Factor (PDGF), Platelet Rich Plasma (PRP), Epidermal Growth Factors (EGF), Basic Fibroblast Growth Factors (BFGF), Granulocyte Colony Stimulating Factor (G-CSF), Talactoferrin ALFA, Thrombin Peptide, and Keratinocyte Growth Factor (KGF)), By Distribution Channel, By End Users, By Indication, Geography (North America, Europe, Asia-Pacific, Europe, South America, Middle East and Africa) – Industry Trends and Forecast to 2024
Report Access: databridgemarketresearch.com/reports/global-active-wound-...
About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Data Bridge Market Research
Visit Blog: databridgemarketresearch.com/blog/
Follow us on LinkedIn: www.linkedin.com/company/data-bridge-market-research
This release was published on openPR.
News-ID: 718644 • Views: 189More releases